(Q38378354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

main subject

metastatic breast cancer

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Gloria Ribas Despuig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Ana Lluch

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Juan Miguel Cejalvo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Octavio Burgués

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Cristina Mongort

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Elisa Alonso

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Maider Ibarrola-Villava

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Begoña Bermejo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

María Teresa Martínez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Andrés Cervantes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

14 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

69-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27628192%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-016-3980-z

23 March 2020

exact match

0 references

cites work

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Translational implications of tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

Concordance of genomic alterations between primary and recurrent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z

A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3980-Z